Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes

Epilepsia

Volumn 39, Issue 8, 1998, Pages 878-883

  Bélanger, Stacey ^a   Coulombe, Geneviève ^a   Carmant, Lionel ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Generalized epilepsy; Lamotrigine; Partial epilepsy; Vigabatrin

Indexed keywords

LAMOTRIGINE; VIGABATRIN;

ADOLESCENT; ADULT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL;

EID: 0031868680     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01184.x     Document Type: Article

References (40)

1. Sloviter RS. On the relationship between neuropathology and pathophysiology in the epileptic hippocampus of human and experimental animals. Hippocampus 1994;4:250-3.
2. Snead OC III. Basic mechanisms of generalized absence seizures. Ann Neurol 1995;37:146-57.
3. Avoli M. GABA mediated synchronous potentials and seizure generation. Epilepsia 1996;37:1035-42.
4. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification for epileptic syndromes. Epilepsia 1989;30:389-99.
5. Gale K. GABA and epilepsy: basic concepts from preclinical research. Epilepsia 1992;33(suppl 5):S3-12.
6. Petroff OA, Rothman DL, Behar KL, Collins TL, Mattson RH. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 1996;47:1567-71.
7. Leach M, Harden CM, Miller AA. Pharmacological studies of lamotrigine, a novel potential antiepileptic drug, II: neurochemical studies on the mechanism of action. Epilepsia 1986;27:490-7.
8. Stefani A, Spadoni F, Siniscalchi A, Bernardi G. Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. Eur J Pharmacol 1996;307:113-6.
9. Appleton RE. Vigabatrin in the management of generalized seizures in children. Seizure 1995;4:45-8.
10. Dulac O, Chiron C, Luna D, et al. Vigabatrin in childhood epilepsy. J Child Neurol 1991;6(suppl 2):S30-7.
11. Schlumberger E, Chavez F, Palacios L, Key E, Pajot N, Dulac O. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia 1994;35:359-67.
12. Besag FMC, Wallace SJ, Dulac O, Alving J, Spencer SC, Hosking G. Lamotrigine for the treatment of epilepsy in childhood. J Pediatr 1995;127:991-7.
13. Motte J, Trevathan E, Arvidsson JF, Barrera MM, Mullens EL, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med 1997;337:1807-12.
14. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. Br Med J 1997;314:180-1.
15. Rimmer EM, Richens A. Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy. Lancet 1984;1:1989-90.
16. Gram L, Klosterskov P, Dam M. Gamma-vinyl GABA: a double-blind placebo controlled trial in partial epilepsy. Ann Neurol 1985; 17:262-6.
17. Sivenius J, Ylinen A, Murros K, Mumford JP, Riekkinen PJ. Vigabatrin in drug-resistant partial epilepsy: a 5-year follow-up study. Neurology 1991;41:562-5.
18. Tartara A, Manni R, Galimberti CA, et al. Six year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Acta Neurol Scand 1992;86:247-51.
19. Dalla Bernardina B, Fontana E, Vigevano F, et al. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study. Epilepsia 1995;36: 687-91.
20. Appleton RE. The role of vigabatrin in the management of infantile epileptic syndromes. Neurology 1993;43(suppl 5):S21-3.
21. Pitkänen A, Ylinen A, Matilainen R, et al. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study. Arch Neurol 1993;50: 24-9.
22. Uldall P, Alving J, Gram L, et al. Vigabatrin in pediatric epilepsy - an open study. J Child Neurol 1991;6(suppl 2):S38-44.
23. Gibbs JM, Appleton RE, Rosenbloom L. Vigabatrin in intractable childhood epilepsy: a retrospective study. Pediatr Neurol 1992;8: 338-40.
24. Gram L, Dulac O. Antiepileptic drug-induced worsening of seizures in adults and children. Epilepsia 1995;36(suppl 3):S57.
25. Lortie A, Chiron C, Mumford J, Dulac O. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology 1993;43(suppl 5):S24-7.
26. Baxter PS, Gardner-Medwin D, Barwick DD, Ince P, Livingston J, Murdoch-Eaton D. Vigabatrin monotherapy in resistant neonatal seizures. Seizure 1995;4:57-9.
27. Steriade M, Amzica F, Contreras D. Cortical and thalamic cellular correlates of electroencephalographic burst-suppression. Electroencephalogr Clin Neurophysiol 1994;90:1-16.
28. Chiron C, Dulac O, Beaumont D, Palacios L, Pajot N, Mumford J. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991;6(suppl 2):S52-9.
29. Aicardi J, Mumford JP, Dumas C, Wood S. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups. Epilepsia 1996;37: 638-12.
30. Chiron C, Dumas C, Dulac O, et al. Vigabatrin versus hydrocortisone as first-line monotherapy in infantile spasms due to tuberous sclerosis. Epilepsia 1995;36(suppl 3):S265.
31. Jawad S, Yuen WC, Peck AW, Hamilton MJ, Oxley JR, Richens A. Lamotrigine: single dose pharmacokinetics and initial 1 week experience in refractory epilepsy. Epilepsy Res 1987;1:194-201.
32. Sander JW, Treviol-Bittencourt PC, Hart YM, Patsalos PM, Shorvon SD. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy. Epilepsy Res 1990;7:226-9.
33. Goa KL, Ross SP, Chrisp P. Lamotrigine. An update of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993;46:152-76.
34. Farrell K. Canadian retrospective study of lamotrigine in intractable childhood epilepsy. Epilepsia 1996;37(suppl 4):65.
35. Veggiotti P, Cieuta C, Rey E, Dulac O. Lamotrigine in infantile spasms. Lancet 1994;344;1375-6.
36. Buchanan N. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability. Seizure 1995;4:233-6.
37. Sutula T, Cascino G, Cavazos J, Parada I, Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989;26:321-30.
38. Sloviter RS. The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann Neurol 1994;35:640-54.
39. B-mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. J Neurophysiol 1994;71:2576-81.
40. A receptors. Neuron 1990;4:759-65.